Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • American Society of Clinical Oncology sales and marketing update

    American Society of Clinical Oncology, Alexandria, Va. Business: Cancer ASCOs CancerLinQ LLC nonprofit subsidiary said 36 U.S. health practices have agreed to use the subsidiarys health information technology (HIT) …

    Published on 5/2/2016
  • Amgen, Astellas sales and marketing update

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan Business: Endocrine/Metabolic Astellas and Amgen Astellas BioPharma K.K. launched Repatha evolocumab in Japan to treat …

    Published on 5/2/2016
  • Celgene sales and marketing update

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Cancer The U.K.s NICE recommended against the use of Vidaza azacitidine from Celgene to treat patients at least 65 years of age who are not eligible for hematopoietic …

    Published on 5/2/2016
  • Chugai, Taisho Pharmaceutical Holdings, Roche sales and marketing update

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Taisho Pharmaceutical Holdings Co. Ltd. (Tokyo:4581), Tokyo, Japan Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Musculoskeletal Chugai and Taisho …

    Published on 5/2/2016
  • Epigenomics sales and marketing update

    Epigenomics AG (Xetra:ECX), Berlin, Germany Business: Diagnostic Epigenomics and Polymedco Inc. (Cortlandt Manor, N.Y.) launched Epigenomics Epi proColon blood-based colorectal cancer screening test in the U.S. The …

    Published on 5/2/2016
  • Novartis sales and marketing update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cardiovascular The U.K.s NICE issued draft guidance recommending the use of Entresto sacubitril/valsartan from Novartis to treat heart failure in patients …

    Published on 5/2/2016
  • ViiV Healthcare, Medicines Patent Pool sales and marketing update

    ViiV Healthcare, Brentford, U.K. Medicines Patent Pool, Geneva, Switzerland Business: Infectious The partners added 19 additional lower middle income countries (LMICs) to a deal granting Medicines Patent Pool (MPP) …

    Published on 5/2/2016
  • Bristol-Myers, CHAI sales and marketing update

    Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Clinton Health Access Initiative Inc. (CHAI), Boston, Mass. Business: Infectious Bristol-Myers will donate to CHAI enough Daklinza daclatasvir to treat 10,000 …

    Published on 4/25/2016
  • CombiMatrix sales and marketing update

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. Business: Diagnostic CombiMatrix launched the CombiPGD test for single gene disorders and chromosomal translocations. The preimplantation genetic diagnosis test identifies…

    Published on 4/25/2016
  • Invitae, CMS sales and marketing update

    Invitae Corp. (NYSE:NVTA), San Francisco, Calif. Centers for Medicare & Medicaid Services, Baltimore, Md. Business: Diagnostic Invitae said CMS began reimbursing Invitaes multigene tests for hereditary breast and …

    Published on 4/25/2016
  • PTC sales and marketing update

    PTC Therapeutics Inc. (NASDAQ:PTCT), South Plainfield, N.J. Business: Musculoskeletal The U.K.s NICE issued draft guidance recommending the use of Translarna ataluren from PTC to treat nonsense mutation Duchenne …

    Published on 4/25/2016
  • Raptor sales and marketing update

    Raptor Pharmaceutical Corp. (NASDAQ:RPTP), Novato, Calif. Business: Infectious Raptor launched Quinsair in Germany and Denmark to manage chronic pulmonary infections due to Pseudomonas aeruginosa in patients with cystic…

    Published on 4/25/2016
  • Sanofi sales and marketing update

    Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Cancer The U.K.s NICE issued final guidance recommending Jevtana cabazitaxel from Sanofi to treat metastatic hormone-relapsed prostate cancer in patients whose …

    Published on 4/25/2016
  • Trovagene, Stratose LLC sales and marketing update

    Trovagene Inc. (NASDAQ:TROV), San Diego, Calif Stratose LLC, Atlanta, Ga. Business: Diagnostic Trovagene said Stratose gave preferred provider status to Trovagene and will cover the companys Precision Cancer Monitoring …

    Published on 4/25/2016
  • Agilent, Bristol-Myers sales and marketing update

    Agilent Technologies Inc. (NYSE:A), Santa Clara, Calif. Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Pharmacogenetics Agilents Dako company launched PD-L1 IHC 28-8 pharmDx in the EU to detect PD-L1 …

    Published on 4/18/2016
  • Biogen, Swedish Orphan Biovitrum sales and marketing update

    Biogen Inc. (NASDAQ:BIIB), Cambridge, Mass. Swedish Orphan Biovitrum AB (SSE:SOBI), Stockholm, Sweden Business: Hematology Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier …

    Published on 4/18/2016
  • Gilead sales and marketing update

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Infectious Germanys Institute for Quality and Efficiency in Health Care (IQWiG) issued a dossier of early benefit assessment for Genvoya tenofovir …

    Published on 4/18/2016
  • J&J sales and marketing update

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Business: Infectious Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in an dossier of early benefit assessment that an added benefit was not …

    Published on 4/18/2016
  • Novartis sales and marketing update

    Novartis (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Cardiovascular Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier of early benefit assessment that there is an indication …

    Published on 4/18/2016
  • Pfizer, Merck KGaA sales and marketing update

    Pfizer Inc. (NYSE:PFE), New York, N.Y. Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Cancer Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said in a dossier assessment that added benefit of …

    Published on 4/18/2016
  • Interpace Diagnostics, Galaxy Health sales and marketing update

    Interpace Diagnostics Group Inc. (NASDAQ:IDXG), Parsippany, N.J. Galaxy Health Network, Arlington, Texas Business: Diagnostic Interpace said Galaxy Health Network will cover all of Interpaces molecular pathology tests …

    Published on 4/11/2016
  • Advanced Accelerator Applications sales and marketing update

    Advanced Accelerator Applications S.A. (NASDAQ:AAAP), Saint Genis Pouilly, France Business: Cancer Advanced Accelerator launched an expanded access program (EAP) in the U.S. for Lutathera to treat inoperable, …

    Published on 4/4/2016
  • CombiMatrix, Blue Cross Blue Shield, Cigna Corp. sales and marketing update

    CombiMatrix Corp. (NASDAQ:CBMX), Irvine, Calif. Blue Cross Blue Shield, Chicago, Ill. Cigna Corp. (NYSE:CI), Bloomfield, Conn. Business: Diagnostic CombiMatrix said Cigna and three BCBS affiliates -- Premera, Life Wise …

    Published on 4/4/2016
  • Merrimack sales and marketing update

    Merrimack Pharmaceuticals Inc. (NASDAQ:MACK), Cambridge, Mass. Business: Cancer The 2016 National Comprehensive Cancer Network (NCCN) guidelines will include Merrimacks Onivyde irinotecan (MM-398) in combination with …

    Published on 4/4/2016
  • Novartis sales and marketing update

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Autoimmune Germanys Institute for Quality and Efficiency in Health Care (IQWiG) said an added benefit was not proven for Cosentyx secukinumab vs. …

    Published on 4/4/2016

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993